ArticleTranslational vision science & technology2025
Genomic Profiling of Intraocular Leiomyomas Reveals Recurrent Copy Number Alterations.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Leiomyomas are benign smooth muscle tumors that commonly present in the uterus, soft tissue, skin, and gastrointestinal tract but in rare cases can also arise within the eye. Notably, intraocular leiomyomas often show slightly different histopathologic and immunohistochemical features, referred to as mesectodermal morphology, given their presumed neural crest origin. Genetic and cytogenetic alterations of intraocular leiomyomas, as well as their association with various clinical and histopathologic features, have not been previously studied. Methods: We identified eight patients diagnosed with intraocular leiomyoma and performed targeted next-generation sequencing, whole transcriptome RNA sequencing, and chromosomal copy number analysis on those with sufficient residual tissue. Results: Copy number analysis demonstrated multiple, recurrent whole-chromosome losses (including losses of 1, 2, 3, 10, 15q, 22q) suggestive of near haploidization of the genome. DNA sequencing did not reveal any pathogenic single-nucleotide variants, deep deletions, amplifications, or structural rearrangements. Whole-transcriptome RNA sequencing performed in a subset of cases did not show any pathogenic or likely pathogenic gene fusions. Tumors with mesenchymal versus mesectodermal morphology and those with or without histologically worrisome features did not show any differences in their copy number profile. Conclusions: Genetic and cytogenetic features of intraocular leiomyomas are different from the leiomyomas of uterine and deep soft tissues, as well as from uveal melanocytic tumors. Translational Relevance: Recurrent whole-chromosome losses in the absence of mutations or fusions are common among intraocular leiomyomas and may aid in the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.